Associations of Central and Peripheral Blood Pressure with the Renin-angiotensin-aldosterone System in Healthy Young Adults: the African-PREDICT Study
Overview
Affiliations
This study investigated associations of brachial and central blood pressure (BP) with detailed renin-angiotensin-aldosterone system (RAAS) components in a healthy young population stratified according to ethnicity and sex. We included healthy black men (n = 285) and women (n = 304) and white men (n = 278) and women (n = 305) aged 20-30 years old. We derived central systolic BP (cSBP), measured clinic and 24-h systolic and diastolic BP. Aldosterone and equilibrium angiotensin levels were assessed and used for calculating angiotensin-derived markers for plasma renin activity (PRA-S, Angiotensin I + Angiotensin II), angiotensin-converting enzyme (ACE-S, Angiotensin II/Angiotensin I), and two markers for adrenal effects of angiotensin II, the aldosterone-to-renin ratio (ARR-S, Aldosterone/PRA-S) and the aldosterone-to-angiotensin II-ratio (AA2-R, Aldosterone/Angiotensin II) Young black men and women presented with lower RAAS components and higher cSBP compared to their white counterparts (all p ≤ 0.001). In multivariable-adjusted regression analyses, positive associations of cSBP with ARR-S and AA2-R and negative associations with PRA-S and angiotensin II were found for black women (all p ≤ 0.001); this pattern was also observed for 24-h and clinic BP (p ≤ 0.045). A similar trend of RAAS associations was present in black men but only for clinic BP (all p ≤ 0.047). In white men, negative associations between clinic SBP and PRA-S, angiotensin II and aldosterone were detected (all p ≤ 0.048). No associations were observed in white women. Positive associations of central and peripheral BP with the ratio of aldosterone to PRA-S and angiotensin II only in healthy, young black adults suggest that relative aldosterone excess may contribute to early hypertension development in this group.
Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities.
Gafane-Matemane L, Craig A, Kruger R, Alaofin O, Ware L, Jones E J Hum Hypertens. 2024; 39(2):95-110.
PMID: 38698111 PMC: 11867975. DOI: 10.1038/s41371-024-00913-6.
Shoemaker R, Poglitsch M, Huang H, Vignes K, Srinivasan A, Cockerham C Int J Mol Sci. 2023; 24(16).
PMID: 37628909 PMC: 10454898. DOI: 10.3390/ijms241612728.
Gafane-Matemane L, Kruger R, van Rooyen J, Gona P, Schutte A J Cardiovasc Dev Dis. 2022; 9(5).
PMID: 35621841 PMC: 9144018. DOI: 10.3390/jcdd9050130.